Antibody response in cattle vaccinated against bluetongue serotype 8 in Italy.

To assess the immunogenicity of Zulvac 8 Bovis (a commercial inactivated vaccine against bluetongue virus serotype 8 - BTV8) under field conditions, 71 cattle vaccinated according to manufacturer schedule in Verona province (Italy) were tested for the presence of BTV8 neutralizing antibodies at 21, 29, 36, 43, 49, 102 and 201 days post-vaccination (dpv). Another group of 528 BTV8 vaccinated cattle in Mantova province (Italy) was also tested once between 113 and 174 dpv. The vaccine was able to elicit an immune response in 69 (97.2%) and 346 (65.5%) animals of the Verona and Mantova groups, respectively.

[1]  J. Wood,et al.  Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. , 2009, Vaccine.

[2]  C. Cariou,et al.  Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle , 2009, Veterinary Record.

[3]  F. Conraths,et al.  Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions. , 2009, Vaccine.

[4]  P. Mellor,et al.  Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006. , 2008, Preventive veterinary medicine.

[5]  Guy Hendrickx,et al.  Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands. , 2008, Preventive veterinary medicine.

[6]  P. Mellor,et al.  Bluetongue virus: virology, pathogenesis and immunity. , 2008, Veterinary research.

[7]  C. Saegerman,et al.  Bluetongue Epidemiology in the European Union , 2008, Emerging infectious diseases.

[8]  J. Sánchez-Vizcaíno,et al.  Vaccines against bluetongue in Europe. , 2008, Comparative immunology, microbiology and infectious diseases.

[9]  B. Bonfini,et al.  Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2. , 2007, Veterinaria italiana.

[10]  Stanley S. Grossel,et al.  Takashi Kotoyori, Critical Temperatures for the Thermal Explosion of Chemicals, Elsevier, Oxford, UK and San Diego, CA, 2005, (406pp., $215 and 195 Euros). , 2006 .

[11]  P. Calistri,et al.  Neutralising antibody response in cattle after vaccination with monovalent modified-live vaccine against bluetongue virus serotype 2. , 2004, Veterinaria italiana.

[12]  F. Monaco,et al.  Monovalent modified-live vaccine against bluetongue virus serotype 2: immunity studies in cows. , 2004, Veterinaria italiana.

[13]  A. Giovannini,et al.  Bluetongue in Italy: Part I. , 2004, Veterinaria italiana.

[14]  W. Tabachnick.  Culicoides and the global epidemiology of bluetongue virus infection. , 2004, Veterinaria italiana.

[15]  E. Greiner,et al.  The epidemiology of bluetongue. , 1994, Comparative immunology, microbiology and infectious diseases.

[16]  N J MacLachlan,et al.  The pathogenesis and immunology of bluetongue virus infection of ruminants. , 1994, Comparative immunology, microbiology and infectious diseases.

[17]  A. Conte,et al.  Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. , 2009, Veterinary microbiology.

[18]  A. Giovannini,et al.  Vaccination in the control strategy of bluetongue in Italy. , 2004, Developments in biologicals.